Slideshow

Adjunctive Cannabidiol Therapy in Schizophrenia

Author(s):

Brian Miller, MD, PhD, MPH

New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.

Related Videos
clozapine
40 years
Tierney/AdobeStock
Julyuela/AdobeStock
schizophrenia
2025
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
Related Content
smoking
March 27th 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

Heather Burrell Ward, MD
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
March 10th 2025

How the Study of Muscarinic Receptors Is Transforming Schizophrenia Treatment

Khutaija Noor, MBBS, FCR
More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle
May 11th 2021

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD
schizophrenia
March 3rd 2025

Presenting Our March Theme: Schizophrenia

Leah Kuntz
Stephen McLeod-Bryant, MD
February 28th 2025

Learning How to Actively Listen: In Conversation With Stephen McLeod-Bryant, MD

Leah Kuntz Stephen McLeod-Bryant, MD
© 2025 MJH Life Sciences

All rights reserved.